Overview

Bayer AG is a German multinational corporation active in pharmaceuticals, consumer health products and agricultural sciences. Headquartered in Leverkusen, in the state of North Rhine-Westphalia, the company combines chemical and biological research with global manufacturing and sales operations. It is widely recognized for introducing and marketing the non-prescription analgesic known as Aspirin, among other products.

Logo Bayer.svg

History

Founded in 1863 by industrialists in Germany, Bayer began as a dye and chemical manufacturer and expanded into pharmaceuticals and fine chemicals during the late 19th and early 20th centuries. Research at the company led to the development and commercialization of acetylsalicylic acid under the trade name Aspirin. Over more than a century, Bayer diversified into multiple life-science fields and grew through acquisitions and international expansion.

Structure and principal activities

Bayer's operations are typically organized into business divisions that focus on different markets and technologies. Commonly referenced areas include:

  • Pharmaceuticals – prescription medicines in areas such as cardiology, oncology and women's health.
  • Consumer Health – over-the-counter remedies, nutritional products and everyday health-care items.
  • Crop Science – seeds, crop protection products and agricultural services (now often addressed under separate brands or business units).
  • Animal Health – products for livestock and companion animals (subject to corporate reorganizations).

Importance, applications and notable facts

Bayer has played a prominent role in the development of modern pharmaceuticals and agricultural chemicals, contributing to drug discovery, medical devices and plant science. Its trademark and emblem are widely known in many countries. In recent decades the company has undergone substantial restructuring, acquisitions and legal scrutiny related to some products and business combinations, while continuing to invest in research and development to bring new therapies and crop technologies to market.